Wockhardt Buys French Pharma Company for $265 Million

Wockhardt Ltd. (Mumbai), a pharmaceutical and biotechnology company, has acquired Negma Laboratories (Paris), the fourth-largest pharmaceutical group in France, for $265 million. The acquisition, Wockhardt’s fifth in Europe, means that European sales will account for more than 60% of the company’s total. Negma, with annual sales of $150 million, has a portfolio of 172 patents, and a range of pharma products in various stages of development. “Negma is a unique acquisition for Wockhardt,” says Habil Khorakiwala, chairman of Wockhardt...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers